This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Sep 2;105(35):12643-4.

doi: 10.1073/pnas.0806877105. Epub 2008 Aug 27.

Overcoming obstacles to the effective immunotherapy of human cancer

Steven A Rosenberg¹

Affiliations

PMID: 18753635
PMCID: PMC2529039
DOI: 10.1073/pnas.0806877105

Comment

Overcoming obstacles to the effective immunotherapy of human cancer

Steven A Rosenberg. Proc Natl Acad Sci U S A. 2008.

. 2008 Sep 2;105(35):12643-4.

doi: 10.1073/pnas.0806877105. Epub 2008 Aug 27.

Author

Steven A Rosenberg¹

Affiliation

¹ Surgery Branch, National Cancer Institute, Bethesda, MD 20892, USA. sar@nih.gov

PMID: 18753635
PMCID: PMC2529039
DOI: 10.1073/pnas.0806877105

No abstract available

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Comment on

Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice.
Bai A, Higham E, Eisen HN, Wittrup KD, Chen J. Bai A, et al. Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13003-8. doi: 10.1073/pnas.0805599105. Epub 2008 Aug 22. Proc Natl Acad Sci U S A. 2008. PMID: 18723683 Free PMC article.

Similar articles

CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer.
Wang RF. Wang RF. Hum Immunol. 2008 Nov;69(11):811-4. doi: 10.1016/j.humimm.2008.08.276. Epub 2008 Sep 24. Hum Immunol. 2008. PMID: 18817828 Review.
Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice.
Bai A, Higham E, Eisen HN, Wittrup KD, Chen J. Bai A, et al. Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13003-8. doi: 10.1073/pnas.0805599105. Epub 2008 Aug 22. Proc Natl Acad Sci U S A. 2008. PMID: 18723683 Free PMC article.
Signaling defects in anti-tumor T cells.
Frey AB, Monu N. Frey AB, et al. Immunol Rev. 2008 Apr;222:192-205. doi: 10.1111/j.1600-065X.2008.00606.x. Immunol Rev. 2008. PMID: 18364003 Free PMC article. Review.
Rescue of Tolerant CD8+ T Cells during Cancer Immunotherapy with IL2:Antibody Complexes.
Klevorn LE, Berrien-Elliott MM, Yuan J, Kuehm LM, Felock GD, Crowe SA, Teague RM. Klevorn LE, et al. Cancer Immunol Res. 2016 Dec;4(12):1016-1026. doi: 10.1158/2326-6066.CIR-16-0159. Epub 2016 Nov 1. Cancer Immunol Res. 2016. PMID: 27803062 Free PMC article.
[Cancer immunotherapy. Importance of overcoming immune suppression].
Malvicini M, Puchulo G, Matar P, Mazzolini G. Malvicini M, et al. Medicina (B Aires). 2010;70(6):565-70. Medicina (B Aires). 2010. PMID: 21163748 Review. Spanish.

See all similar articles

Cited by

Demethylation of cancer/testis antigens and CpG ODN stimulation enhance dendritic cell and cytotoxic T lymphocyte function in a mouse mammary model.
Sun JZ, Gao L, Gao L, Wang W, Du N, Yang J, Wan L, Liu F, Wang LL, Yu L. Sun JZ, et al. Biomed Res Int. 2013;2013:196894. doi: 10.1155/2013/196894. Epub 2013 Nov 4. Biomed Res Int. 2013. PMID: 24294600 Free PMC article.
Immunotherapeutic approaches for glioma.
Okada H, Kohanbash G, Zhu X, Kastenhuber ER, Hoji A, Ueda R, Fujita M. Okada H, et al. Crit Rev Immunol. 2009;29(1):1-42. doi: 10.1615/critrevimmunol.v29.i1.10. Crit Rev Immunol. 2009. PMID: 19348609 Free PMC article. Review.
Antiangiogenic therapy improves the antitumor effect of adoptive cell immunotherapy by normalizing tumor vasculature.
Shi S, Chen L, Huang G. Shi S, et al. Med Oncol. 2013 Dec;30(4):698. doi: 10.1007/s12032-013-0698-1. Epub 2013 Aug 28. Med Oncol. 2013. PMID: 23982676 Review.
Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer.
Shrimali RK, Yu Z, Theoret MR, Chinnasamy D, Restifo NP, Rosenberg SA. Shrimali RK, et al. Cancer Res. 2010 Aug 1;70(15):6171-80. doi: 10.1158/0008-5472.CAN-10-0153. Epub 2010 Jul 14. Cancer Res. 2010. PMID: 20631075 Free PMC article.
The combination of apatinib and antigen-specific DC-induced T cells exert antitumor effects by potently improving the immune microenvironment of osteosarcoma.
Hu T, Sun W, Jin Y, Dong Y, Liu W, Sun Z, Xiang Y, Chen Y. Hu T, et al. Heliyon. 2024 Aug 8;10(16):e36016. doi: 10.1016/j.heliyon.2024.e36016. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39224314 Free PMC article.

See all "Cited by" articles

References

1. Bai A, Higham E, Eisen HN, Wittrup KD, Chen J. Rapid tolerization of virus-activated tumor-specific CD+ T cells in prostate tumors of TRAMP mice. Proc Natl Acad Sci USA. 2008;105:13003–13008. - PMC - PubMed
1. Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME. Adoptive cell transfer: A clinical path to effective cancer immunotherapy. Nat Rev Cancer. 2008;8:299–308. - PMC - PubMed
1. Rosenberg SA, et al. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin-2. J Am Med Assoc. 1994;271:907–913. - PubMed
1. Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: Moving beyond current vaccines. Nat Med. 2004;10:909–915. - PMC - PubMed
1. Dudley ME, et al. Cancer regression and autoimmunity in patients following clonal repopulation with anti-tumor lymphocytes. Science. 2002;298:850–854. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database